Validity of medication-based co-morbidity indices in the Australian elderly population

Agnes Vitry, Soo Ann Wong, Elizabeth E. Roughead, Emmae Ramsay, John Barratt

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Objectives: To determine the validity of two medication-based co-morbidity indices, the Medicines Disease Burden Index (MDBI) and Rx-Risk-V in the Australian elderly population. Methods: In Phase I, the sensitivity and specificity of both indices were determined in 767 respondents from wave 6 of the Australian Longitudinal Study of Ageing (ALSA). Medication-defined index disease categories were compared to self-reported medical conditions. Correlation with self-rated health was examined and Cox proportional hazards models were used to assess the predictive validity for mortality. Phase II verified the predictive ability of Rx-Risk-V in a sample of 213,191 veterans from Australian Department of Veterans' Affairs (DVA) database. Results: MDBI and Rx-Risk-V scores could be calculated for 28% and 73% of the ALSA sample respectively. Both indices had high specificities and low to moderate sensitivities compared to self-reported medical conditions. Total weighted scores were significantly related to self-rated health (p<0.001). Both indices were predictive of mortality (Hazard Ratio (HR) =3.690 (95% Cl 2.264-6.015) for MDBI and HR 1.079 (95% Cl 1.045-1.114) for Rx-Risk-V. The predictive validity for mortality of Rx-Risk-V was confirmed using DVA data (HR= 1.090, 95% Cl 1.088-1.092). Conclusions: Medication-based co-morbidity indices Rx-Risk-V and MDBI are valid measures of co-morbidity. However, Rx-Risk-V detects more comorbidity in the Australian elderly population and is likely to be a more suitable index to use in administrative datasets, particularly where studies include large numbers of outpatients. Journal Compilation

LanguageEnglish
Pages126-130
Number of pages5
JournalAustralian and New Zealand journal of public health
Volume33
Issue number2
DOIs
Publication statusPublished - 1 Apr 2009
Externally publishedYes

Keywords

  • Chronic disease/drug therapy
  • Co-morbidity
  • Drug prescriptions
  • Risk adjustment/methods

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Vitry, Agnes ; Wong, Soo Ann ; Roughead, Elizabeth E. ; Ramsay, Emmae ; Barratt, John. / Validity of medication-based co-morbidity indices in the Australian elderly population. In: Australian and New Zealand journal of public health. 2009 ; Vol. 33, No. 2. pp. 126-130.
@article{4340e7e94e8140d3949e9085314e48d7,
title = "Validity of medication-based co-morbidity indices in the Australian elderly population",
abstract = "Objectives: To determine the validity of two medication-based co-morbidity indices, the Medicines Disease Burden Index (MDBI) and Rx-Risk-V in the Australian elderly population. Methods: In Phase I, the sensitivity and specificity of both indices were determined in 767 respondents from wave 6 of the Australian Longitudinal Study of Ageing (ALSA). Medication-defined index disease categories were compared to self-reported medical conditions. Correlation with self-rated health was examined and Cox proportional hazards models were used to assess the predictive validity for mortality. Phase II verified the predictive ability of Rx-Risk-V in a sample of 213,191 veterans from Australian Department of Veterans' Affairs (DVA) database. Results: MDBI and Rx-Risk-V scores could be calculated for 28{\%} and 73{\%} of the ALSA sample respectively. Both indices had high specificities and low to moderate sensitivities compared to self-reported medical conditions. Total weighted scores were significantly related to self-rated health (p<0.001). Both indices were predictive of mortality (Hazard Ratio (HR) =3.690 (95{\%} Cl 2.264-6.015) for MDBI and HR 1.079 (95{\%} Cl 1.045-1.114) for Rx-Risk-V. The predictive validity for mortality of Rx-Risk-V was confirmed using DVA data (HR= 1.090, 95{\%} Cl 1.088-1.092). Conclusions: Medication-based co-morbidity indices Rx-Risk-V and MDBI are valid measures of co-morbidity. However, Rx-Risk-V detects more comorbidity in the Australian elderly population and is likely to be a more suitable index to use in administrative datasets, particularly where studies include large numbers of outpatients. Journal Compilation",
keywords = "Chronic disease/drug therapy, Co-morbidity, Drug prescriptions, Risk adjustment/methods",
author = "Agnes Vitry and Wong, {Soo Ann} and Roughead, {Elizabeth E.} and Emmae Ramsay and John Barratt",
year = "2009",
month = "4",
day = "1",
doi = "10.1111/j.1753-6405.2009.00357.x",
language = "English",
volume = "33",
pages = "126--130",
journal = "Community Health Studies",
issn = "1326-0200",
publisher = "Public Health Association of Australia Inc.",
number = "2",

}

Validity of medication-based co-morbidity indices in the Australian elderly population. / Vitry, Agnes; Wong, Soo Ann; Roughead, Elizabeth E.; Ramsay, Emmae; Barratt, John.

In: Australian and New Zealand journal of public health, Vol. 33, No. 2, 01.04.2009, p. 126-130.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Validity of medication-based co-morbidity indices in the Australian elderly population

AU - Vitry, Agnes

AU - Wong, Soo Ann

AU - Roughead, Elizabeth E.

AU - Ramsay, Emmae

AU - Barratt, John

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Objectives: To determine the validity of two medication-based co-morbidity indices, the Medicines Disease Burden Index (MDBI) and Rx-Risk-V in the Australian elderly population. Methods: In Phase I, the sensitivity and specificity of both indices were determined in 767 respondents from wave 6 of the Australian Longitudinal Study of Ageing (ALSA). Medication-defined index disease categories were compared to self-reported medical conditions. Correlation with self-rated health was examined and Cox proportional hazards models were used to assess the predictive validity for mortality. Phase II verified the predictive ability of Rx-Risk-V in a sample of 213,191 veterans from Australian Department of Veterans' Affairs (DVA) database. Results: MDBI and Rx-Risk-V scores could be calculated for 28% and 73% of the ALSA sample respectively. Both indices had high specificities and low to moderate sensitivities compared to self-reported medical conditions. Total weighted scores were significantly related to self-rated health (p<0.001). Both indices were predictive of mortality (Hazard Ratio (HR) =3.690 (95% Cl 2.264-6.015) for MDBI and HR 1.079 (95% Cl 1.045-1.114) for Rx-Risk-V. The predictive validity for mortality of Rx-Risk-V was confirmed using DVA data (HR= 1.090, 95% Cl 1.088-1.092). Conclusions: Medication-based co-morbidity indices Rx-Risk-V and MDBI are valid measures of co-morbidity. However, Rx-Risk-V detects more comorbidity in the Australian elderly population and is likely to be a more suitable index to use in administrative datasets, particularly where studies include large numbers of outpatients. Journal Compilation

AB - Objectives: To determine the validity of two medication-based co-morbidity indices, the Medicines Disease Burden Index (MDBI) and Rx-Risk-V in the Australian elderly population. Methods: In Phase I, the sensitivity and specificity of both indices were determined in 767 respondents from wave 6 of the Australian Longitudinal Study of Ageing (ALSA). Medication-defined index disease categories were compared to self-reported medical conditions. Correlation with self-rated health was examined and Cox proportional hazards models were used to assess the predictive validity for mortality. Phase II verified the predictive ability of Rx-Risk-V in a sample of 213,191 veterans from Australian Department of Veterans' Affairs (DVA) database. Results: MDBI and Rx-Risk-V scores could be calculated for 28% and 73% of the ALSA sample respectively. Both indices had high specificities and low to moderate sensitivities compared to self-reported medical conditions. Total weighted scores were significantly related to self-rated health (p<0.001). Both indices were predictive of mortality (Hazard Ratio (HR) =3.690 (95% Cl 2.264-6.015) for MDBI and HR 1.079 (95% Cl 1.045-1.114) for Rx-Risk-V. The predictive validity for mortality of Rx-Risk-V was confirmed using DVA data (HR= 1.090, 95% Cl 1.088-1.092). Conclusions: Medication-based co-morbidity indices Rx-Risk-V and MDBI are valid measures of co-morbidity. However, Rx-Risk-V detects more comorbidity in the Australian elderly population and is likely to be a more suitable index to use in administrative datasets, particularly where studies include large numbers of outpatients. Journal Compilation

KW - Chronic disease/drug therapy

KW - Co-morbidity

KW - Drug prescriptions

KW - Risk adjustment/methods

UR - http://www.scopus.com/inward/record.url?scp=65349106005&partnerID=8YFLogxK

U2 - 10.1111/j.1753-6405.2009.00357.x

DO - 10.1111/j.1753-6405.2009.00357.x

M3 - Article

VL - 33

SP - 126

EP - 130

JO - Community Health Studies

T2 - Community Health Studies

JF - Community Health Studies

SN - 1326-0200

IS - 2

ER -